Natera, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Natera, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.4×Over the last 3 years its own operating cash paid for 41% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Higher than 65% of Healthcare companies in United States.
Cash Locked Ratio
$13For every $100 of sales, $13 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $30 tied up three years earlier.
Less money tied up than 73% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$23Sales grew 181% in 3 years; of every extra $100 of sales, $23 became extra profit.
Higher than 54% of Healthcare companies in United States.
Asset Productivity Ratio
+181% / +72%In 3 years sales changed by +181% while total assets changed by +72%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
2.7×Debt due within a year is covered 2.7 times by its yearly operating cash.
Higher than 76% of Healthcare companies in United States.
Cash Cushion Ratio
+1%Cash, after subtracting all debt, equals 1% of its market value (net cash).
Lower than 65% of Healthcare companies in United States.
Tangible Assets Ratio
79%Of every $100 the company owns, $79 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 53% of Healthcare companies in United States.
Tangible Net Worth Ratio
70%Of every $100 of net worth, $70 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 56% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Natera, Inc. made a loss over the last year. Natera, Inc. owes $0.31 for every $1 it owns. Natera, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossNatera, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
31.76The share price is 31.76 times Natera, Inc.'s book value per share, higher than 97% of Healthcare companies in United States.
Market cap
$57.9 BThe total market value of all of Natera, Inc.'s shares at today's price (share price × number of shares), larger than 97% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$1.8 BWhat Natera, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$12.64Net worth divided by the number of shares. The share price of $401.37 is 31.8 times this, which is the P/B above.
Return on equity (ROE)
-12.5%Natera, Inc. lost 12.5% of its shareholders' money over the last year, higher than 70% of Healthcare companies in United States.
Owes vs Owns
0.31×Natera, Inc. owes $0.31 for every $1 it owns (low), lower than 59% of Healthcare companies in United States.
Dividend yield
NoneNatera, Inc. does not currently pay a dividend.
Revenue growth
+36%Revenue rose 36% in the year to Dec 2025, and grew 41% a year on average over 3 years.
Profit growth
LossNatera, Inc. made a loss in each of the last two years.
Profit margin
-9.0%Natera, Inc. lost $9 for every $100 of revenue.
Interest cover
Not coveredNatera, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashNatera, Inc. held $862 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Natera, Inc.: $57.9 B ÷ $1.8 B (30 Jun 2026) = 31.8.
What is Natera, Inc.'s return on equity?
Natera, Inc. lost 12.5% of its shareholders' money over the last year, higher than 70% of Healthcare companies in United States.
How much does Natera, Inc. owe compared with what it owns?
Natera, Inc. owes $0.31 for every $1 it owns (low), lower than 59% of Healthcare companies in United States.
Does Natera, Inc. pay a dividend?
No. Natera, Inc. does not currently pay a dividend.
Is Natera, Inc.'s revenue growing?
Revenue rose 36% in the year to Dec 2025, and grew 41% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.